Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely created TPD approaches. On this evaluation, we focus on both equally preclinical experiments and medical trials to provide a comprehensive summary of the security and clinical performance of PROTACs and MGDs in hematologic malignancies over the past twenty https://codyqxbfj.luwebs.com/32320948/top-u-73122-secrets